Recombinant DNA (genetic engineering): Evolution
Timeline
The milestones from first idea to today
| Year | Milestone |
|---|---|
| 1972 | Herbert Boyer and Stanley Cohen meet at a joint US and Japan meeting on bacterial DNA in Hawaii [1] |
| 1973 | Their collaboration produces its first success in spring [1] |
| 1975 | Scientists and lawyers meet at Asilomar, California, to manage the risks of the new method; the NIH guidelines for such research follow in 1976 [6] |
| 1976 | Boyer and venture capitalist Robert Swanson found Genentech [1] |
| 1977 | Boyer and Itakura have bacteria make a mammalian protein, somatostatin, for the first time [1] |
| 1978 | Boyer and Keiichi Itakura prepare the human insulin gene for production in bacteria [1] |
| 1982 | The FDA approves Humulin, the first biotechnology product on the market [1] |
as of 2026-11-11
Lineage
The technologies it came from and the ones that came from it
Enables 5- Inl Insulin therapy Human insulin made by bacteria was the first recombinant medicine, approved in 1982 [1].
- mAb Monoclonal antibodies Most therapeutic antibodies today are made in genetically engineered cells and are partly or fully human in sequence.
- GM Genetically modified crops Genetically modified crops carry genes moved by recombinant methods.
- PFm Precision fermentation Microbes engineered to make proteins for food and industry apply the same principle outside medicine.
- Seq DNA sequencing Cloning DNA in bacteria gave early sequencers enough copies of a single piece to read.
- Cas CRISPR gene editing Gene editing changes DNA in place inside living cells instead of moving genes in carriers.
as of 2026-11-11
Sources
- Herbert W. Boyer and Stanley N. Cohen Science History Institute
- Asilomar Conference (1975) Embryo Project Encyclopedia, Arizona State University (Abigail Cave), 2024